STOCK TITAN

Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Prestige Consumer Healthcare Inc. (NYSE:PBH) will release its fiscal 2024 first quarter earnings on August 3, 2023. The company will host a conference call at 8:30 a.m. ET to discuss the results. Participants can join the call via phone or through the live webcast on the Investor Relations page of www.prestigeconsumerhealthcare.com. A conference call replay will be available for one week on the company's Investor Relations page.
Positive
  • None.
Negative
  • None.

TARRYTOWN, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 first quarter earnings release on Thursday, August 3, 2023 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.

A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com


FAQ

When will Prestige Consumer Healthcare release its fiscal 2024 first quarter earnings?

Prestige Consumer Healthcare will release its fiscal 2024 first quarter earnings on August 3, 2023.

What time will the conference call to discuss the results take place?

The conference call to discuss the results will take place at 8:30 a.m. ET.

How can participants join the conference call?

Participants can join the conference call via phone or through the live webcast on the Investor Relations page of www.prestigeconsumerhealthcare.com.

Will there be a conference call replay available?

Yes, a conference call replay will be available for one week on the company's Investor Relations page.

Prestige Consumer Healthcare Inc.

NYSE:PBH

PBH Rankings

PBH Latest News

PBH Stock Data

3.68B
49.92M
1.33%
107.33%
4.26%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TARRYTOWN